Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
Evaluation of the efficacy and safety of multiple subcutaneous injections of SHR-1918 in patients with hyperlipidemia in poor control: a multicenter, randomized, double-blind, placebo-controlled phase II clinical trials